BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 22997443)

  • 1. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Pacini F; Castagna MG; Brilli L; Pentheroudakis G;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii110-9. PubMed ID: 22997443
    [No Abstract]   [Full Text] [Related]  

  • 2. Contemporary management of papillary carcinoma of the thyroid gland.
    Rosenbaum MA; McHenry CR
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):317-29. PubMed ID: 19275510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and therapy of differentiated thyroid gland carcinomas].
    Mann K
    Internist (Berl); 2002 Feb; 43(2):174-85. PubMed ID: 11963755
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
    Fallahi P; Ferrari SM; Galdiero MR; Varricchi G; Elia G; Ragusa F; Paparo SR; Benvenga S; Antonelli A
    Semin Cancer Biol; 2022 Feb; 79():180-196. PubMed ID: 33249201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and treatment of differentiated thyroid carcinoma].
    Mora J
    Rev Esp Med Nucl; 2003; 22(5):349-59; quiz 360-2. PubMed ID: 14534014
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of microcarcinomas (papillary and medullary) of the thyroid.
    Wu LS; Milan SA
    Curr Opin Oncol; 2013 Jan; 25(1):27-32. PubMed ID: 23042124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Follow-up care for differentiated thyroid cancer].
    Hüfner M; Reiners C
    Dtsch Med Wochenschr; 1986 Nov; 111(45):1732-4. PubMed ID: 3536387
    [No Abstract]   [Full Text] [Related]  

  • 8. [The treatment of differentiated thyroid cancer].
    Hubold C; Buchmann I; Lehnert H
    Dtsch Med Wochenschr; 2011 Apr; 136(17):891-5. PubMed ID: 21523640
    [No Abstract]   [Full Text] [Related]  

  • 9. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
    Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience.
    Pelizzo MR; Boschin IM; Toniato A; Pagetta C; Piotto A; Bernante P; Casara D; Pennelli G; Rubello D
    Nucl Med Commun; 2004 Jun; 25(6):547-52. PubMed ID: 15167512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of differentiated carcinoma of the thyroid gland].
    Mimura T; Ito K
    Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1184-9. PubMed ID: 9379097
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression.
    Khan M; Syed AA; Khan AI; Hussain SR; Urooj N
    Updates Surg; 2018 Mar; 70(1):121-127. PubMed ID: 28550398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment strategy for patients with papillary microcarcinoma].
    Sugitani I; Fujimoto Y; Yamada K
    Nihon Rinsho; 2007 Nov; 65(11):2045-8. PubMed ID: 18018568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up of thyroid cancer patients with favorable prognostic indicators.
    Leboulleux S; Baudin E; Schlumberger M
    Ann Endocrinol (Paris); 2003 Feb; 64(1):64-7. PubMed ID: 12707639
    [No Abstract]   [Full Text] [Related]  

  • 15. Minimal thyroid cancer: clinical consequences.
    Böttger IG
    Recent Results Cancer Res; 1988; 106():139-45. PubMed ID: 3285409
    [No Abstract]   [Full Text] [Related]  

  • 16. [Medullary carcinoma of the thyroid gland].
    Zarrilli L; Marzano LA; Porcelli A; Zarrilli S; D'Ajello M
    Chir Ital; 1994; 46(4):33-6. PubMed ID: 7882440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillary and follicular thyroid carcinoma.
    Schlumberger MJ; Torlantano M
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):601-13. PubMed ID: 11289737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary thyroid cancer: monitoring and therapy.
    Tuttle RM; Leboeuf R; Martorella AJ
    Endocrinol Metab Clin North Am; 2007 Sep; 36(3):753-78, vii. PubMed ID: 17673127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillary thyroid carcinoma: the impact of therapy in 576 patients.
    Mazzaferri EL; Young RL; Oertel JE; Kemmerer WT; Page CP
    Medicine (Baltimore); 1977 May; 56(3):171-96. PubMed ID: 859443
    [No Abstract]   [Full Text] [Related]  

  • 20. Medullary thyroid carcinoma.
    Modigliani E
    Curr Ther Endocrinol Metab; 1994; 5():112-7. PubMed ID: 7704692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.